# A Phase I/II Trial of a Tetravalent Live Attenuated DEN Vaccine in Flavivirus Antibody Naive Children

> **NCT01843621** · PHASE1,PHASE2 · COMPLETED · sponsor: **U.S. Army Medical Research and Development Command** · enrollment: 7 (actual)

## Conditions studied

- Dengue

## Interventions

- **BIOLOGICAL:** DEN vaccine F17

## Key facts

- **NCT ID:** NCT01843621
- **Lead sponsor:** U.S. Army Medical Research and Development Command
- **Sponsor class:** FED
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** 2005-02
- **Final completion:** 2009-02
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2018-11-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01843621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01843621, "A Phase I/II Trial of a Tetravalent Live Attenuated DEN Vaccine in Flavivirus Antibody Naive Children". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01843621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*